A combination of lectin-affinity electrophoresis and antibody-affinity blotting was used for the qualitative determination of molecular species of α-foetoprotein. Concanavalin A and erythrophytohaemagglutinin were used s lectins. This method was able to quickly discrimin te between the molecular species of α-foetoprotein of recurrent ovarian yolk sac tumour and those of non-malignant liver diseases and cord sera at term, using only 3 μΐ of sera containing 200 μg/l of α-foetoprotein. The results indicate that this assay method might be seful for the differential diagnosis of recurrent yolk sac tumour from drug-or blood transfusion^induced liver diseases and for the monitoring of the serum α-foetoprotein level of patients with yolk sac tumour producing less than 200 μg/l of α-foetoprotein. ! 300 μg/l might be due to the recurrence of the tumour i α-Foetoprotein is classified a typical tumour marker or regeneration of the host hepatocytes, after treatj for hepatocellular carcinoma and malignant germ cell ment with hepatotoxic anticancer agents or by blood tumpurs with yolk s e elements (1^-3). In ovarian transfusion (3, 7, 8) . tumours with yolk sac elements, the elevated serum α-foetoprotein level in patients shows a gpod corre-It has been reported that α-foetoprotein produced by lation with the clinical Status of malignancy in more the yolk sac, foetal liver or regenerating hepatocytes than 75% cases; in addition, an increase in serum a-with non-malignant liver diseases can be differentiated foetoprotein after a transient decrease due to surgical by different reactivities against concanavalin A or resection of the tumour is a sign of reeurrence (3 -6). erythrophytohaemagglutinin (9 -11). This heterogeIn the follow-up study after ie surgical resection of neity of α-foetoprotein with respect to lectin affinity yolk s e tumours, it is important to detennine whether is ascribed tp differences in the carbohydrate moiety the slight increase of serum α-foetoprotein arpund (12).
Summary:
A combination of lectin-affinity electrophoresis and antibody-affinity blotting was used for the qualitative determination of molecular species of α-foetoprotein. Concanavalin A and erythrophytohaemagglutinin were used s lectins. This method was able to quickly discrimin te between the molecular species of α-foetoprotein of recurrent ovarian yolk sac tumour and those of non-malignant liver diseases and cord sera at term, using only 3 μΐ of sera containing 200 μg/l of α-foetoprotein. The results indicate that this assay method might be seful for the differential diagnosis of recurrent yolk sac tumour from drug-or blood transfusion^induced liver diseases and for the monitoring of the serum α-foetoprotein level of patients with yolk sac tumour producing less than 200 μg/l of α-foetoprotein. ! 300 μg/l might be due to the recurrence of the tumour i α-Foetoprotein is classified a typical tumour marker or regeneration of the host hepatocytes, after treatj for hepatocellular carcinoma and malignant germ cell ment with hepatotoxic anticancer agents or by blood tumpurs with yolk s e elements (1^-3). In ovarian transfusion (3, 7, 8) . tumours with yolk sac elements, the elevated serum α-foetoprotein level in patients shows a gpod corre-It has been reported that α-foetoprotein produced by lation with the clinical Status of malignancy in more the yolk sac, foetal liver or regenerating hepatocytes than 75% cases; in addition, an increase in serum a-with non-malignant liver diseases can be differentiated foetoprotein after a transient decrease due to surgical by different reactivities against concanavalin A or resection of the tumour is a sign of reeurrence (3 -6) . erythrophytohaemagglutinin (9 -11) . This heterogeIn the follow-up study after ie surgical resection of neity of α-foetoprotein with respect to lectin affinity yolk s e tumours, it is important to detennine whether is ascribed tp differences in the carbohydrate moiety the slight increase of serum α-foetoprotein arpund (12) .
Recently a highly sensitive technique for the detection of small amounts of α-foetoprotein was reported by Taketa et al. (10, 13) . In the present work we applied this rapid and sensitive method to the clinical differential diagnosis of the early stages of recurrent yolk sac tumour from non-malignant liver diseases.
labelled with horseradish peroxidase. Colour was developed by incubating the nitrocellulose with 3,3'-diaminobenzidine tetrahydrochloride (Polyscience, USA) and H 2 O 2 in Tris-buffered salinc.
Chemicals
All chemicals were used of reagent grade.
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Materials and Methods

Sera from patients
Frozen samples of sera were obtained from patients with yolk sac tumour without recurrent disease but with hepatic disorders (2 cases) and with pathologically confirmed recurrent disease (10 cases, 7 of these with chronic liver diseases indicated by a considerable elevation of serum α-foetoprotein from 150 to 500 pg/l). Samples were also collected from patients with nonmalignant Hver diseases including liver cirrhosis (30 cases) and from cord sera at tenn (30 cases).
Determination of serum α-foetoprotein level Serum α-foetoprotein levels were examined using radioimmunoassay (RIA) (14) and Mancmfs method (15) with a Japanese α-foetoprotein Standard (Nippon Βίο-Test Lab., Japan) (13) s a reference.
Specific antibody to α-foetoprotein
Specific antiserum against human α-foetoprotein was produced in a horse by weekly subcutaneous injections of l mg of purified α-foetoprotein (16) emulsified in Freunds complete adjuvant. Specific antibody against α-foetoprotein was purified by affinity chromatography on BrCN-activated Sepharose 4B (Pharmacia, Sweden) coupled to human α-foetoprotein (14) .
Isolation of molecular species of α-foetoprotein α-Foetoprotein was fractionated by concanavalin A -or erythrophytohaemagglutinin -affinity agarose gel electrophoresis followed by blotting s described previously (10, 13) . Briefly, antibody-coated nitrocellulose papers were prepared by incubating with 100 mg/1 affinity-purified horse antibody to human α-foetoprotein, then by fixing with glutaraldehyde vapour, neutralizing with NaBH 4 , followed by washing with Tris-buffered saline (20 mmol/1 Tris HC1, pH 7.5, 500 mmol/1 NaCl, Trisbuffered saline). The nitrocellulose was blocked with 5 g/l Tween 20 in Tris-buffered saline for 30 min, then washed with Tris-buffered saline.
Electrophoresis was carried out on 10 g/l agarose gel plates (Litex HSA, Litex, Denmark) in barbital/barbital-Na buffer, pH 8.6 containing l g/l concanavalin A (Sigma, USA) or 0.5 g/l erythrophytohaemagglutinin (Sigma, USA) or without lectins. Three microlitres of patients' sera or reference α-foetoprotein at various concentrations (diluted with the gel buffer or afoetoprotein-free normal human sera) was applied to the plate and electrophoresis was performed at 4 °C. a-Foetoprotein-free sera were prepared by passing sera from healthy subjects through an anti-human α-foetoprotein antibody-affinity column. After lectin-affinity electrophoresis, α-foetoprotein was transfered, by capillary blotting, to nitrocellulose coated with antibody to α-foetoprotein. The nitrocellulose was then washed twice in 0.5 g/l Tween 20 in Tris-buffered saline, then treated with rabbit anti-human α-foetoprotein IgG (DAKO, Denmark), followed by treatment with swine antibody against rabbit IgG
Results and Discussion
Post-operative anticancer chemotherapy with a combination of vincristine, actin mycin D and cyclophosphamide has been employed in patients with recurrent yolk sac tumours. Approximately 70% of patients treated in this way experienced liver injury, due at least in part to the side effects of the therapy. In these cases serum α-foetoprotein levels generally tend to increase. A method to determine at an early stage whether the increase in serum α-foetoprotein is due to liver injury or the recurrence of yolk sac tumour (tab. 1) would therefore be clinically advantageous.
The antibody-affinity blotting method showed sensitive results with a detection lirnit for α-foetoprotein of less than 3 μΐ of a solution containing 200 μ §/1. In the qualitative analysis, α-foetoprotein bands could be identified in a sample containing less than 100 μg/l (300 pg) of α-foetoprotein ( fig. 1 ). By this sensitive method, all the yolk sac tumour α-foetoprotein from patients with recurrent yolk sac tumour (10/10) was separated into two bands of concanavalin A-reactive minor and concanavalin A-non-reactive major α-foetoprotein ( fig. l a, fig.2 ). In contrast, all the α-foetoprotein obtained from cord sera (30/30) and from the sera of patients with non-malignant liver diseases (30/ 30) showed a single concanavalin A-reactive band (figs. 2, 4). The same result was also observed in the sera of clinically tumour-free patients with liver injury (data not shown). When erythrophytohaemagglutinin was used s the lectin, all the yolk sac tumour afoetoprotein from the patients with recurrent yolk sac tumours (10/10) was fractionated into 3 bands, i.e. strong, weak and n n-reactive bands. However, erythrophytohaemagglutinin affinity electrophoresis separated normal α-foetoprotein into one or two minor reactive bands arid a major non-reactive band ( fig.  l b, fig. 3 ). One case (case 8) indicated co-elevation of yolk sac tumour α-foetoprotein and normal afoetoprotein (tab. 1). In this case, α-foetoprotein was separated into concanavalin A-reactive and concanavalin A^non-reactive bands with the same colour intensity (fig. 4) . The patient had clinically been diagnosed s recurrent yolk sac tumour with chronic liver damage, so that the result described above eoincided well with the clinieal diagnosis. The interrel; lation between the types of α-foetoprotein bands and \ .
-r the pathophysiological Status of increased a-foetoprov.
.
tein production is schematically summarized in figure 5 . Heterogeneous reactivity of α-foetoprotein against lectins has been detected by lectin-affinity-crossed immunoelectrophoresis (9, 11, 17) s well s the combination of lectin-affinity mini-column chromatography with the radioimmunoassay of α-foetoprotein (l 8, 19). However, the sensitivity of the former method for α-foetoprotein is around 2 mg/1, unless radiolabeled antibody to α-foetoprotein is available. This means that the method described in this paper may have 20-50 times greater sensitivity than that of the former method. As shown by Govindarajan et al. (19) , coneanavalin A-reactive and non-reactive α-foetoprotein fractions in the sera of patients with liver-and germ celltumours can be quantitatively determined in 200 μΐ of serum at α-foetoprotein concentrations s low s 58 μ §/1. This means that the quantitation of bound and non-bound fractions of α-foetoprotein by the latter method is clearly superior to the qualitative analysis presented here. But in this latter method it should be noted that serum samples must be appropriately diluted before passing through the concanavalin A column, to avoid incorrect results due to the presence of other glycoproteins with mannose-type carbohydrate moieties.
Thus, the main advantage of the antibody-affinityblotting method is the fact that very low volumes of serum (3 μΐ) are sufficient for analysis. In comparison with established techniques, the method seems to have a significantly higher sensitivity. Qualitative analysis was based on the identificatioii of the typical reactiVe patterns of α-foetoprotein bands with lectins for afoetoprotein concentrations s low s 100 μ §/1. This novel method avoids the troublesome manipulation of serum samples, and it is potentially usef l for the rapid and early differential diagnosis of recurrent yolk sac tumour and non-malignant liver diseases.
